Replies to post #423487 on NorthWest Biotherapeutics Inc (NWBO)

[Gus McCrae]

This post is nonsense as it relates to my concerns about what happened to the Cognate/CRL manufacturing agreement between the 2019 Form 10-K and the 2020 Form 10-K.

I said someone should call DI and ask whether there is a manufacturing agreement with Cognate today. Not whether there is some super secret framework for manufacturing later. I swear, you talk out of both sides of your mouth and the back of your head.

Not every agreement has to be posted and disclosed at the moment some presume.

Literally nobody is presuming this. Terrible straw man, even for you.

The law and the securities regulations allow for confidentiality especially when it involves regulatory process.

The law does allow for confidentiality when parties enter into a material definitive agreement. All you have to do is redact the portions of the agreement that you believe qualify for confidential treatment from the exhibit before filing and put some magic language at the top of the exhibit. Read here for more details: Confidential Treatment Requests. There is nothing in the securities laws that allows you not to disclose an agreement that is considered material.

Since a contract would be a contingent agreement upon approval, and because the original agreement says that in fact, there would be nothing to disclose at this time.

What in the wide wide world of sports are you trying to say here???

[JRIII]

Dude, just take the L. There is no contract. Secret agreements floating in the imagination like unicorns are a sad reflection of how far this whole thing has regressed.

My belief is that NWBO has been told in no uncertain terms by the FDA that their SAP is rejected, that they cannot change the endpoints on a 16-year-old trial, and so, therefore, they have no need for a contract with CRL. That's where things are. Sorry if that disappoints you or ruins your figgy plum pudding dream.